Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • API Reference

© 2026 Annolyse.

Plain-language analysis of NZX company announcements

Source-backed metrics, clear analytical briefings, and plain-English context built from actual company filings. No broker consensus, no price targets, no buy/sell recommendations.

Companies

Start with the company.

100 NZX companies have published briefing histories, latest results, and company pages.

View companies→
NTLNew Talisman Gold MinesFY21 - FY26IFTInfratilFY21 - FY26GMTGoodman Property TrustHY26 - FY26TAHThird Age Health ServicesFY22 - FY26IPRIperionFY21 - FY26BFGBurger Fuel GroupHY22 - FY26ARBArborGen HoldingsHY22 - FY26TRUTruscreen GroupHY22 - FY26IKEikeGPS GroupFY21 - FY26GXHGreen Cross HealthHY23 - FY26CCCCooks Coffee CompanyFY22 - FY26NZMNZMEHY24 - FY25

Recent briefings

Latest analysis from the coverage desk.

View all briefings→
New Talisman Gold Mines (NTL)•FY26

PBT swung to a $2.2m loss as FY25's impairment reversal dropped out

Operating cash outflow widened to NZ$2.0m, showing a cash-hungry gold explorer behind a distorted profit swing.

New Talisman swung from a profit before tax of NZ$4.1m in FY25 to a loss before tax of NZ$2.2m in FY26 (-153.9%), with net profit after tax falling to -NZ$2.3m from NZ$4.0m (-155.8%). This is not a clean like-for-like comparison: FY25's result was lifted by a disclosed impairment reversal, so the headline swing overstates any deterioration in ongoing operations rather than reflecting a comparable operating collapse. Revenue rose to NZ$0.053m from NZ$0.024m (+120.8%), but the base is trivial for an exploration-stage miner and the percentage move carries a basis discontinuity from the near-zero prior-year denominator, so it should not be read as a clean like-for-like trend.

2 July 2026

Read briefing→
Third Age Health Services (TAH)•FY26

PBT up 25.7% on ARC scale, full-year dividend reset to 8.0c

Aged-care consolidation lifted earnings and revenue mix, but a halved dividend and weaker cash conversion signal a clear reinvestment pivot.

29 May 2026

Read briefing→
Iperion (IPR)•FY26

Loss narrowed 35.3% but cash fell 63.5% as Iperion's runway tightens

Operating losses keep absorbing the balance sheet; total equity fell 84.5% to NZ$0.1m while the Pathoglaze licence still produces no revenue.

29 May 2026

Read briefing→

Featured insights

Cross-company metrics and market-wide trends.

NZX cash conversion comparison

Operating cash flow versus EBITDA across the Annolyse coverage set, using each company's most recent published result.

View report→

NZX dividend coverage comparison

Payout ratios against NPAT and free cash flow for the latest published result from each covered company.

View report→

NZX leverage comparison

Net debt and net debt / EBITDA across the Annolyse coverage set, ranked by the latest reported leverage position.

View report→

NZX earnings quality comparison

PBT versus NPAT divergence across covered NZX companies, highlighting tax, fair-value, and non-operating distortions.

View report→

NZX revenue growth comparison

Revenue growth rates across covered NZX companies, ranked by each company's latest reported period.

View report→

NZX working capital comparison

Debtor days and inventory days across covered NZX companies, showing where cash is tied up in receivables or stock.

View report→
Explore all 17 market insights →

Get reporting-season briefings

Get newly published NZX result briefings and the highest-signal cross-company updates by email.